Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses

5

Jan 2026

COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses

This study shows that SARS-CoV-2 infection and vaccination generate strong, highly specific spike-binding immune responses with only modest effects on immunity to endemic common cold coronaviruses. Pre-existing coronavirus immunity patterns remain largely intact, indicating that SARS-CoV-2 has integrated into the human viral landscape without broadly reshaping cross-reactive protection.

Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds

5

Jan 2026

Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds

This global macroeconomic analysis estimates that diabetes mellitus will cost the world economy INT$10.2 trillion between 2020 and 2050, rising to INT$78.8 trillion when unpaid informal caregiving is included. Using a health-augmented economic model across 204 countries, the study shows that informal care is the dominant and most underestimated driver of diabetes-related economic losses worldwide.

AI method sharply improves noise removal in brain imaging

5

Jan 2026

AI method sharply improves noise removal in brain imaging

Obtaining clearer functional MRI data about the brain and its disorders is possible using artificial intelligence, according to Boston College researchers who reported recently in Nature Methods that they developed an AI-assisted method to remove "noise", or image distortions, caused by movement, heartbeat, and other factors.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.